124 related articles for article (PubMed ID: 22083193)
1. [Clinical analyses of oral squamous cell carcinoma patients showing a complete response to chemotherapy with S-1 alone].
Nakamura M; Koga M; Aoki M; Iwamoto O; Koga C; Kusukawa J
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1841-3. PubMed ID: 22083193
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of palliative chemotherapy with S-1 for oral cancer patients].
Koga M; Aoki M; Anegawa E; Tezuka M; Iwamoto O; Koga C; Kusukawa J
Gan To Kagaku Ryoho; 2007 May; 34(5):719-23. PubMed ID: 17496444
[TBL] [Abstract][Full Text] [Related]
3. S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy.
Yokota T; Onozawa Y; Boku N; Hamauchi S; Tsushima T; Taniguchi H; Todaka A; Machida N; Yamazaki K; Fukutomi A; Yasui H
Jpn J Clin Oncol; 2011 Dec; 41(12):1351-7. PubMed ID: 21980053
[TBL] [Abstract][Full Text] [Related]
4. [A case of oral squamous cell carcinoma responding to S-1].
Harada K; Tamatani T; Bando T; Yoshida H
Gan To Kagaku Ryoho; 2007 Sep; 34(9):1455-8. PubMed ID: 17876145
[TBL] [Abstract][Full Text] [Related]
5. [An advanced case of squamous cell carcinoma in the left buccal mucosa, upper gingiva, and maxillary sinus (T4N0M0) showing a complete response to chemotherapy with TS-1].
Yamamoto K; Obara S; Mishima K; Nakamura H; Yoshimura Y
Gan To Kagaku Ryoho; 2004 Apr; 31(4):635-7. PubMed ID: 15114716
[TBL] [Abstract][Full Text] [Related]
6. [A case of advanced oral squamous cell carcinoma responding to concurrent radiotherapy with S-1].
Harada K; Kawashima Y; Uchida D; Yoshida H
Gan To Kagaku Ryoho; 2007 May; 34(5):745-7. PubMed ID: 17496449
[TBL] [Abstract][Full Text] [Related]
7. Multi-institutional phase II trial of S-1 in patients with oral squamous cell carcinoma.
Harada K; Sato M; Ueyama Y; Nagayama M; Hamakawa H; Nagahata S; Yoshimura Y; Osaki T; Ryoke K;
Anticancer Drugs; 2008 Jan; 19(1):85-90. PubMed ID: 18043133
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.
Sakuramoto S; Sasako M; Yamaguchi T; Kinoshita T; Fujii M; Nashimoto A; Furukawa H; Nakajima T; Ohashi Y; Imamura H; Higashino M; Yamamura Y; Kurita A; Arai K;
N Engl J Med; 2007 Nov; 357(18):1810-20. PubMed ID: 17978289
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of preoperative concurrent chemoradiation therapy with S-1 in patients with T4 oral squamous cell carcinoma.
Nomura T; Murakami R; Toya R; Teshima K; Nakahara A; Hirai T; Hiraki A; Nakayama H; Yoshitake Y; Ota K; Obayashi T; Yamashita Y; Oya N; Shinohara M
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1347-52. PubMed ID: 19628343
[TBL] [Abstract][Full Text] [Related]
10. [The feasibility of oral fluoropyrimidines as adjuvant chemotherapy after resection and local coagulation therapy of colorectal liver metastases].
Narita T; Seshimo A; Itabashi M; Aratake K; Ogawa S; Hirosawa T; Hashimoto T; Amano K; Kameoka S
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1821-4. PubMed ID: 22083190
[TBL] [Abstract][Full Text] [Related]
11. [A case report of tongue squamous cell carcinoma showing a complete response to TS-1].
Ikeda H; Takebe Y; Irie A; Mizoguchi Y; Yamada K; Shibahara K; Inokuchi T
Gan To Kagaku Ryoho; 2003 May; 30(5):677-9. PubMed ID: 12795100
[TBL] [Abstract][Full Text] [Related]
12. High response rates in patients with pancreatic cancer using the novel oral fluoropyrimidine S-1.
Hayashi K; Imaizumi T; Uchida K; Kuramochi H; Takasaki K
Oncol Rep; 2002; 9(6):1355-61. PubMed ID: 12375048
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma.
Nakazawa M; Ohnishi T; Ohmae M; Chisoku H; Yui S; Iwai S; Sumi T; Fukuda Y; Kishino M; Yura Y
Int J Clin Pharmacol Res; 2005; 25(3):115-22. PubMed ID: 16366419
[TBL] [Abstract][Full Text] [Related]
14. [Indication of alternate-day treatment with S-1 in patients with oral cancer].
Negishi A; Ogawa M; Kosugi K; Takayama Y; Gomi A; Miyazaki H; Yokoo S
Gan To Kagaku Ryoho; 2015 May; 42(5):569-73. PubMed ID: 25981649
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of S-1 monotherapy as a first-line treatment for elderly patients with advanced nonsmall-cell lung cancer: the Central Japan Lung Study Group trial 0404.
Nishiyama O; Taniguchi H; Kondoh Y; Takada K; Baba K; Saito H; Sugino Y; Yamamoto M; Ogasawara T; Kondo M; Imaizumi K; Hasegawa Y; Suzuki R; Shimokata K;
Anticancer Drugs; 2011 Sep; 22(8):811-6. PubMed ID: 21317767
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of thymidylate synthase (TS) activity for S-1-based chemotherapy in squamous cell carcinoma of the oral cavity.
Koga M; Anegawa E; Yoh J; Tsuyama H; Sakaino H; Iwamoto O; Koga C; Kusukawa J
Br J Oral Maxillofac Surg; 2010 Mar; 48(2):88-93. PubMed ID: 19576666
[TBL] [Abstract][Full Text] [Related]
17. Investigation of optimal schedule of concurrent radiotherapy with S-1 for oral squamous cell carcinoma.
Harada K; Ferdous T; Yoshida H
Oncol Rep; 2007 Nov; 18(5):1077-83. PubMed ID: 17914556
[TBL] [Abstract][Full Text] [Related]
18. [Late phase II study of S-1 in patients with advanced head and neck cancer].
Inuyama Y; Kida A; Tsukuda M; Kohno N; Satake B;
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1381-90. PubMed ID: 11681245
[TBL] [Abstract][Full Text] [Related]
19. Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer.
Tsukuda M; Kida A; Fujii M; Kono N; Yoshihara T; Hasegawa Y; Sugita M;
Br J Cancer; 2005 Oct; 93(8):884-9. PubMed ID: 16189518
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
